Gossamer Bio, Inc. Files Definitive Proxy Statement (DEF 14A)

TL;DR

<b>Gossamer Bio, Inc. has filed its Definitive Proxy Statement (DEF 14A) detailing executive compensation and equity awards for fiscal years 2021-2023.</b>

AI Summary

Gossamer Bio, Inc. (GOSS) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. Gossamer Bio, Inc. filed a DEF 14A form on April 24, 2024. The filing covers the period ending April 16, 2024. The company's principal executive offices are located at 3013 Science Park, San Diego, CA 92121. The SIC code for Gossamer Bio, Inc. is 2834 (Pharmaceutical Preparations). The filing includes information related to equity awards granted and vested for the fiscal years 2021, 2022, and 2023.

Why It Matters

For investors and stakeholders tracking Gossamer Bio, Inc., this filing contains several important signals. This filing is crucial for shareholders to understand executive compensation structures and potential dilution from equity awards. It provides insights into the company's governance practices and how it incentivizes its key personnel.

Risk Assessment

Risk Level: low — Gossamer Bio, Inc. shows low risk based on this filing. The filing is a routine DEF 14A, which is standard for public companies and does not contain new material financial or operational information that would significantly alter risk assessment.

Analyst Insight

Review the executive compensation details and equity award grants to assess potential shareholder dilution and alignment of management incentives.

Key Numbers

• 2024-04-24 — Filing Date (Date the DEF 14A was filed)
• 2024-04-16 — Period of Report (The period the filing is as of)
• 2834 — SIC Code (Standard Industrial Classification code)

Key Players & Entities

• Gossamer Bio, Inc. (company) — Filer name
• 3013 Science Park, San Diego, CA 92121 (address) — Business address

FAQ

Industry Context

Gossamer Bio, Inc. operates in the pharmaceutical preparations industry, focusing on the development of therapeutics.

Regulatory Implications

As a publicly traded company, Gossamer Bio, Inc. is subject to SEC regulations, including the requirement to file proxy statements for shareholder meetings.

What Investors Should Do

1. Analyze the compensation packages for named executive officers.
2. Evaluate the number and value of equity awards granted to assess potential dilution.
3. Review any proposals presented to shareholders for voting.

Key Dates

• 2024-04-24: Filing Date — Definitive Proxy Statement (DEF 14A) filed.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard disclosure document. No prior filing data for comparison is available in the provided text.

Key Financial Figures

• $1 billion — l Head of Healthcare managing more than $1 billion in assets for Credit Suisse Asset Manag

Filing Documents

• goss-20240422.htm (DEF 14A) — 639KB
• goss-20240422_g1.jpg (GRAPHIC) — 147KB
• goss-20240422_g2.jpg (GRAPHIC) — 260KB
• goss-20240422_g3.jpg (GRAPHIC) — 262KB
• goss-20240422_g4.jpg (GRAPHIC) — 116KB
• goss-20240422_g5.jpg (GRAPHIC) — 62KB
• 0001728117-24-000044.txt (&nbsp;) — 3296KB
• goss-20240422.xsd (EX-101.SCH) — 5KB
• goss-20240422_def.xml (EX-101.DEF) — 3KB
• goss-20240422_lab.xml (EX-101.LAB) — 11KB
• goss-20240422_pre.xml (EX-101.PRE) — 7KB
• goss-20240422_htm.xml (XML) — 128KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 21

EXECUTIVE COMPENSATION AND OTHER INFORMATION

EXECUTIVE COMPENSATION AND OTHER INFORMATION 23 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 45 STOCKHOLDER PROPOSALS 46 ANNUAL REPORT 46 STOCKHOLDERS SHARING THE SAME ADDRESS 46 OTHER MATTERS 47 i 3013 Science Park Road San Diego, CA 92121 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON THURSDAY, JUNE 6, 2024 The board of directors of Gossamer Bio, Inc. is soliciting the enclosed proxy for use at the annual meeting of stockholders on June 6, 2024 at 9:00 a.m., Pacific Time. The annual meeting will be a completely virtual meeting, which will be conducted via live webcast. Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be Held on June 6, 2024: This proxy statement and our Annual Report on Form 10-K are available electronically at http://www.proxydocs.com/GOSS. GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING Why am I receiving these materials? We have prepared these proxy materials, including this proxy statement and the related proxy card, because our board of directors is soliciting your proxy to vote at the 2024 annual meeting of stockholders. This proxy statement summarizes information related to your vote at the annual meeting. All stockholders who find it convenient to do so are cordially invited to attend the annual meeting virtually via live webcast. However, you do not need to attend the meeting to vote your shares. Instead, you may simply submit your proxy via the Internet in accordance with the instructions provided on the Notice of Internet Availability of Proxy Materials or if you elected to receive printed copies of the proxy materials, you may submit your proxy via telephone by completing, signing and returning the enclosed proxy card. The proxy materials were first sent or made available to our stockholders on or about April 24, 2024. How can I attend the annual meeting? This year's annual meeting will be accessible only